SCHEMBL7416379

SCHEMBL7416379

CC(=O)N1CCc2cc3c(cc21)c(C)cn3C(=O)C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
NOTUM Q6P988 7/20 0.47
CYP11B2 P19099 7/20 0.41
CYP11B1 P15538 4/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TP53 P04637 2/20 0.38
HSD17B10 Q99714 1/20 0.38
PKM P14618 1/20 0.38
STAT3 P40763 1/20 0.38
STAT1 P42224 1/20 0.38
KLF5 Q13887 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422396 0.80 ALDH1A1 (0.55) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL7423073 0.77 NOTUM (0.51) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL7417711 0.71 NOTUM (0.45) ALDH1A1NOTUMCYP11B2TP53MAPT
SCHEMBL7418832 0.67 KDM4E (0.55) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL21469189 0.67 NOTUM (0.58) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL7373998 0.66 NOTUM (0.59) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL7479611 0.66 NOTUM (0.59) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL8802757 0.66 CA12 (0.45) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL22462287 0.65 NOTUM (0.60) KDM4EALDH1A1HPGDNOTUMCYP11B2
SCHEMBL29803331 0.65 NOTUM (0.60) KDM4EALDH1A1HPGDNOTUMCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994004533-A1 CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-03-03 WO disclosed